Original Research
Published on 02 Apr 2024
Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy
in Obstetric and Pediatric Pharmacology

- 1,568 views
Original Research
Published on 02 Apr 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 27 Mar 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 26 Mar 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 20 Mar 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 20 Mar 2024
in Obstetric and Pediatric Pharmacology
Case Report
Published on 15 Mar 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 14 Mar 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 13 Mar 2024
in Obstetric and Pediatric Pharmacology
Editorial
Published on 12 Mar 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 07 Mar 2024
in Obstetric and Pediatric Pharmacology
General Commentary
Published on 29 Feb 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 28 Feb 2024
in Obstetric and Pediatric Pharmacology
Original Research
Published on 22 Feb 2024
in Obstetric and Pediatric Pharmacology
Clinical Trial
Published on 16 Feb 2024
in Obstetric and Pediatric Pharmacology
Clinical Trial
Published on 05 Feb 2024
in Obstetric and Pediatric Pharmacology
Review
Published on 05 Feb 2024
in Obstetric and Pediatric Pharmacology